Comparison of corneal epitheliotrophic capacities among human platelet lysates and other blood derivatives.
<h4>Purpose</h4>To evaluate the corneal epitheliotropic abilities of two commercialized human platelet lysates (HPLs) and to compare the results with other blood derivatives, including human peripheral serum (HPS) and bovine fetal serum (FBS).<h4>Methods</h4>In vitro, human c...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2017-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0171008&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850230312413429760 |
|---|---|
| author | Chien-Jung Huang Yi-Chen Sun Karen Christopher Amy Shih-I Pai Chia-Ju Lu Fung-Rong Hu Szu-Yuan Lin Wei-Li Chen |
| author_facet | Chien-Jung Huang Yi-Chen Sun Karen Christopher Amy Shih-I Pai Chia-Ju Lu Fung-Rong Hu Szu-Yuan Lin Wei-Li Chen |
| author_sort | Chien-Jung Huang |
| collection | DOAJ |
| description | <h4>Purpose</h4>To evaluate the corneal epitheliotropic abilities of two commercialized human platelet lysates (HPLs) and to compare the results with other blood derivatives, including human peripheral serum (HPS) and bovine fetal serum (FBS).<h4>Methods</h4>In vitro, human corneal epithelial cells were incubated in various concentrations (0%, 3%, 5% and 10%) of blood derivatives. Two commercialized HPLs, including UltraGRO TM (Helios, Atlanta, GA) and PLTMax (Mill Creek, Rochester, MI), were tested and compared with HPS and FBS. Scratch-induced directional wounding assay was performed to evaluate cellular migration. MTS assay was used to evaluate cellular proliferation. Cellular differentiation was examined by scanning electron microscopy, inverted microscopy and transepithelial electrical resistance. Sprague-Dawley rats were used to evaluate the effects of the blood derivatives on corneal epithelial wound healing in vivo. Different blood derivatives were applied topically every 2 hours for 2 days after corneal epithelial debridement. The concentrations of epidermal growth factor (EGF), transforming growth factor -β1 (TGF-β1), fibronectin, platelet-derived growth factor-AB (PDGF-AB), PDGF-BB, and hyaluronic acid in different blood derivatives were evaluated by enzyme-linked immunosorbent assay (ELISA).<h4>Results</h4>In vitro experiments demonstrated statistically comparable epitheliotropic characteristics in cellular proliferation, migration, and differentiation for the two commercialized HPLs compared to FBS and HPS. Cells cultured without any serum were used as control group. The epitheliotropic capacities were statistically higher in the two commercialized HPLs compared to the control group (p<0.05). Among the different concentrations of blood derivatives, the preparations with 3% yielded better outcomes compared to 5% and 10%. In rats, HPLs also caused improved but not statistically significant wound healing compared to HPS. All the blood derivatives had better wound healing ratios than the control group (p<0.05). In the quantification of epitheliotropic factors, UltraGRO and PLTMax had significantly higher levels of EGF, TGF- β1, fibronectin than human peripheral serum (p<0.05).<h4>Conclusions</h4>Both commercialized HPLs showed comparable corneal epitheliotropic abilities and wound healing rates compared to HPS and FBS in the in vivo and in vitro studies. Our results suggest that HPLs may have the potential to replace HPS in the treatment of corneal epithelial problems. |
| format | Article |
| id | doaj-art-cccc03e71a2f4abbaf0307011b89f14d |
| institution | OA Journals |
| issn | 1932-6203 |
| language | English |
| publishDate | 2017-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj-art-cccc03e71a2f4abbaf0307011b89f14d2025-08-20T02:03:54ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-01122e017100810.1371/journal.pone.0171008Comparison of corneal epitheliotrophic capacities among human platelet lysates and other blood derivatives.Chien-Jung HuangYi-Chen SunKaren ChristopherAmy Shih-I PaiChia-Ju LuFung-Rong HuSzu-Yuan LinWei-Li Chen<h4>Purpose</h4>To evaluate the corneal epitheliotropic abilities of two commercialized human platelet lysates (HPLs) and to compare the results with other blood derivatives, including human peripheral serum (HPS) and bovine fetal serum (FBS).<h4>Methods</h4>In vitro, human corneal epithelial cells were incubated in various concentrations (0%, 3%, 5% and 10%) of blood derivatives. Two commercialized HPLs, including UltraGRO TM (Helios, Atlanta, GA) and PLTMax (Mill Creek, Rochester, MI), were tested and compared with HPS and FBS. Scratch-induced directional wounding assay was performed to evaluate cellular migration. MTS assay was used to evaluate cellular proliferation. Cellular differentiation was examined by scanning electron microscopy, inverted microscopy and transepithelial electrical resistance. Sprague-Dawley rats were used to evaluate the effects of the blood derivatives on corneal epithelial wound healing in vivo. Different blood derivatives were applied topically every 2 hours for 2 days after corneal epithelial debridement. The concentrations of epidermal growth factor (EGF), transforming growth factor -β1 (TGF-β1), fibronectin, platelet-derived growth factor-AB (PDGF-AB), PDGF-BB, and hyaluronic acid in different blood derivatives were evaluated by enzyme-linked immunosorbent assay (ELISA).<h4>Results</h4>In vitro experiments demonstrated statistically comparable epitheliotropic characteristics in cellular proliferation, migration, and differentiation for the two commercialized HPLs compared to FBS and HPS. Cells cultured without any serum were used as control group. The epitheliotropic capacities were statistically higher in the two commercialized HPLs compared to the control group (p<0.05). Among the different concentrations of blood derivatives, the preparations with 3% yielded better outcomes compared to 5% and 10%. In rats, HPLs also caused improved but not statistically significant wound healing compared to HPS. All the blood derivatives had better wound healing ratios than the control group (p<0.05). In the quantification of epitheliotropic factors, UltraGRO and PLTMax had significantly higher levels of EGF, TGF- β1, fibronectin than human peripheral serum (p<0.05).<h4>Conclusions</h4>Both commercialized HPLs showed comparable corneal epitheliotropic abilities and wound healing rates compared to HPS and FBS in the in vivo and in vitro studies. Our results suggest that HPLs may have the potential to replace HPS in the treatment of corneal epithelial problems.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0171008&type=printable |
| spellingShingle | Chien-Jung Huang Yi-Chen Sun Karen Christopher Amy Shih-I Pai Chia-Ju Lu Fung-Rong Hu Szu-Yuan Lin Wei-Li Chen Comparison of corneal epitheliotrophic capacities among human platelet lysates and other blood derivatives. PLoS ONE |
| title | Comparison of corneal epitheliotrophic capacities among human platelet lysates and other blood derivatives. |
| title_full | Comparison of corneal epitheliotrophic capacities among human platelet lysates and other blood derivatives. |
| title_fullStr | Comparison of corneal epitheliotrophic capacities among human platelet lysates and other blood derivatives. |
| title_full_unstemmed | Comparison of corneal epitheliotrophic capacities among human platelet lysates and other blood derivatives. |
| title_short | Comparison of corneal epitheliotrophic capacities among human platelet lysates and other blood derivatives. |
| title_sort | comparison of corneal epitheliotrophic capacities among human platelet lysates and other blood derivatives |
| url | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0171008&type=printable |
| work_keys_str_mv | AT chienjunghuang comparisonofcornealepitheliotrophiccapacitiesamonghumanplateletlysatesandotherbloodderivatives AT yichensun comparisonofcornealepitheliotrophiccapacitiesamonghumanplateletlysatesandotherbloodderivatives AT karenchristopher comparisonofcornealepitheliotrophiccapacitiesamonghumanplateletlysatesandotherbloodderivatives AT amyshihipai comparisonofcornealepitheliotrophiccapacitiesamonghumanplateletlysatesandotherbloodderivatives AT chiajulu comparisonofcornealepitheliotrophiccapacitiesamonghumanplateletlysatesandotherbloodderivatives AT fungronghu comparisonofcornealepitheliotrophiccapacitiesamonghumanplateletlysatesandotherbloodderivatives AT szuyuanlin comparisonofcornealepitheliotrophiccapacitiesamonghumanplateletlysatesandotherbloodderivatives AT weilichen comparisonofcornealepitheliotrophiccapacitiesamonghumanplateletlysatesandotherbloodderivatives |